Biomarkers in Drug Discovery and Development
A Handbook of Practice, Application, and Strategy
Reviews of the first edition:If you are interested in biomarkers, and it is difficult to imagine anyone reading this who wouldn't be, then this book is for you. (ISSX)...Provides a good introduction for those new to the area, and yet it can also serve as a detailed reference manual for those practically involved in biomarker implementation. (ChemMedChem)As pharmaceutical companies struggle to improve the success rate and cost-effectiveness of the drug development process, biomarkers have emerged as a valuable tool. Continuing the legacy of a well-established pharmaceutical industry reference, the second edition of Biomarkers in Drug Discovery…
Mehr
CHF 254.00
Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)
V301:
Libri-Titel folgt in ca. 2 Arbeitstagen
Produktdetails
Weitere Autoren: Niewaal, Jonathan van (Hrsg.) / Bleavins, Michael R. (Hrsg.)
- ISBN: 978-1-119-18750-9
- EAN: 9781119187509
- Produktnummer: 29782548
- Verlag: Wiley John + Sons
- Sprache: Englisch
- Erscheinungsjahr: 2020
- Seitenangabe: 591 S.
- Masse: H23.6 cm x B15.6 cm x D3.0 cm 859 g
- Auflage: 2. Auflage
- Gewicht: 859
Über den Autor
RAMIN RAHBARI, MS, MBA, is an expert in biomarkers at Innovative Scientific Management and has previously held similar consulting and research positions at IBM, Cognizant and Pfizer.JONATHAN VAN NIEWAAL, MBA, is Technology Principal at Innovative Scientific Management and has held software development and technology delivery roles in the healthcare, financial services, and technology industries.MICHAEL R. BLEAVINS, PHD, DABT, is the founder of White Crow Innovation, LLC, a Michigan-based drug development consulting company, and cofounder of Michigan Technology and Research Institute.
4 weitere Werke von Ramin (Hrsg.) Rahbari:
Bewertungen
Anmelden